Art
J-GLOBAL ID:201902235874737323   Reference number:19A0341021

Phase III study comparing bevacizumab plus erlotinib (BE) to erlotinib(E) for NSCLC with EGFR mutations (NEJ026)

EGFR変異陽性肺癌においてベバシズマブとエルロチニブ併用療法とエルロチニブ単剤療法の効果を比較する第三相試験(NEJ026)
Author (15):
Material:
Volume: 16th  Page: ROMBUNNO.PS-1  Publication year: 2018 
JST Material Number: L7804B  Document type: Proceedings
Article type: 会議録記事  Country of issue: Japan (JPN)  Language: ENGLISH (EN)
Body text partially displayed:
Body text partially displayed
The beginning part of either the article's body or abstract is displayed (up to about 100 characters).
On JDreamⅢ (charged service), you can see this item immediately after the record is posted.
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addition, medical articles require to login to MyJ-GLOBAL.
...[Body text partially displayed]
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A0341021&from=J-GLOBAL&jstjournalNo=L7804B") }}
JST classification (2):
JST classification
Category name(code) classified by JST.
Tumors(=neoplasms)of respiratory system  ,  Drug therapy(=pharmacotherapy)for tumors 
Substance index (1):
Substance index
Chemical Substance indexed to the Article.

Return to Previous Page